SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-24672"
 

Search: onr:"swepub:oai:DiVA.org:liu-24672" > Residual β-cell fun...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Residual β-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes

Hedman, Christina, 1964- (author)
Linköpings universitet,Internmedicin,Hälsouniversitetet
Frystyk, Jan (author)
Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark
Lindström, Torbjörn, 1952- (author)
Linköpings universitet,Internmedicin,Hälsouniversitetet
show more...
Chen, Jian-Wen (author)
Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark
Flyvbjerg, Allan (author)
Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark
Ørskov, Hans (author)
Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark
Arnqvist, Hans, 1943- (author)
Linköpings universitet,Internmedicin,Cellbiologi,Hälsouniversitetet
show less...
 (creator_code:org_t)
The Endocrine Society, 2004
2004
English.
In: Journal of Clinical Endocrinology and Metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 89:12, s. 6305-6309
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The GH-IGF-I axis is disturbed in patients with type 1 diabetes. Our aim was to investigate whether abnormalities are found in patients in very good glycemic control and, if so, to estimate the role of residual β-cell function. Patients with hemoglobin A 1c (HbA 1c) less than 6% (reference range, 3.6-5.4%) were selected for the study. Twenty-two men and 24 women, aged 41.3 ± 13.8 yr (mean ± SD), with a diabetes duration of 17.8 ± 14.6 yr participated. Healthy controls (15 women and nine men), aged 41.3 ± 13.0 yr, were also studied. Overnight fasting serum samples were analyzed for HbA 1c, C peptide, free and total IGFs, IGF-binding proteins (IGFBPs), GH-binding protein, and IGFBP-3 proteolysis. HbA 1c was 5.6 ± 0.5% in patients and 4.4 ± 0.3% in controls. Total IGF-I was 148 ± 7 μg/liter in patients and 178 ± 9 μg/liter in controls (P < 0.001). Free IGF-I, total IGF-II, IGFBP-3, and GH-binding protein were lower, whereas IGFBP-1, IGFBP-1-bound IGF-I, and IGFBP-2 were elevated compared with control values. Patients with detectable C peptide (≥100 pmol/liter) had higher levels of total IGF-I, free IGF-I, and total IGF-II and lower levels of IGFBP-1 and IGFBP-2 than those with an undetectable C peptide level despite having identical average HbA 1c. IGFBP-3 proteolysis did not differ between patients and controls. Despite very good glycemic control, patients with type 1 diabetes and no endogenous insulin production have low free and total IGF-I. Residual β-cell function, therefore, seems more important for the disturbances in the IGF system than good metabolic control per se, suggesting that portal insulin delivery is needed to normalize the IGF system.

Keyword

MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view